A breakthrough treatment uses nutrient-based nanomedicine to reactivate dormant metabolic pathways in cancer cells, effectively stopping melanoma growth. This new method could transform cancer treatment by combining tyrosine nanomicelles with laser therapy to eradicate cancer swiftly and prevent its recurrence. An international team of researchers has developed a novel method for treating cancer by leveraging nutrients to reactivate dormant metabolic pathways in cancer cells.
The team utilized a widely available amino acid , tyrosine, delivered in nanomedicine form, to alter the metabolism of melanoma, a severe form of skin cancer, thereby inhibiting cancer growth. Australia has the highest rate of skin cancer in the world. This new approach could be combined with current therapies to better treat melanoma.
The technique also has the potential to treat other types of cancer. The study was led by Professor Wenbo Bu from Fudan University and Professor Dayong Jin from the University of Technology Sydney , and recently published in the prestigious journal Nature Nanotechnology . Development of Tyrosine Nanomicelles Tyrosine has limited bioavailability in living organisms.
However, the researchers used a new nanotechnology technique to package it into tiny particles called nanomicelles, which are attracted to cancer cell membranes, and break down easily, boosting absorption. The research team then tested the innovative treatment in mice and in human-derived melanoma cells in the l.